Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Advanced Biological Laboratories Gets CE Mark for SARS-CoV-2 qPCR Assay

Advanced Biological Laboratories Gets CE Mark for SARS-CoV-2 qPCR Assay

Jul 07, 2020
|
staff reporter

NEW YORK ─ Advanced Biological Laboratories said on Monday that it has received CE-IVD marking for its UltraGene Combo2Screen SARS-CoV-2 qPCR assay, enabling its use in the European Union and other countries that accept the designation.

The Luxembourg-based firm said the qPCR detection kit has been validated with SARS-CoV-2 RNA extracted from nasopharyngeal swabs and saliva.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

High Numbers Reported for Russian Vaccine

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Masterpiece Microbiome

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

Limited Trust

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

  2. Cepheid Receives CE Mark for SARS-CoV-2, Flu A/B, RSV Combination Test

  3. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.